DNA repair requires a series of molecular recognition steps that enable DNA damage response proteins to localize at and near DNA lesions. Failure of these responses results in genomic instability and predisposition to malignancy (1) (2) (3) . Binding of the mediator of DNA damage checkpoint 1 (MDC1) protein to the phosphorylated tail of histone H2AX (γH2AX) (4) (5) (6) facilitates the formation of BRCA1 nuclear foci at DSBs (4, 7, 8) . BRCT domain mutations also abrogate BRCA1 ionizing radiation (IR)-induced focus (IRIF) formation and localization to laser-induced DNA double-strand breaks (DSBs) (9) . Thus, this protein-protein interaction domain participates in molecular recognition processes required for homing of BRCA1 to γH2AX-and MDC1-containing DNA repair sites. BRCA1 BRCT mutations disable BRCA1 interactions with two, known ligands, BACH1 (BRCA1-associated C-terminal helicase) (10) and CtIP (CtBP-interacting protein) (11) . However, BACH1 and CtIP deficiency do not substantially alter BRCA1 localization to IRIF or laser-induced DNA DSBs (9) , suggesting that a heretofore undetected BRCT-interacting protein recruits BRCA1 to DNA damageinduced foci.
To address this hypothesis, we purified BRCA1-BARD1 complexes by double immunoaffinity chromatography of an epitope-tagged BARD1 protein (9) . Multiple tryptic fragments derived from the tandem ubiquitin interaction motif (UIM) domain-containing protein, RAP80, were identified in this fraction by mass spectrometry ( fig. S1A ). Endogenous RAP80 coimmunoprecipitated (coIP) with endogenous BRCA1 (Fig. 1A) . This interaction depended on the integrity of the BRCT motifs, because two BRCT-domain clinical missense mutations each disrupted RAP80 binding (Fig. 1B) . Purification of tagged BARD1 after IR revealed the presence of a DNA damage-induced phosphorylation event between the two RAP80 UIMs at serine 101 (S101) (Fig. 1C) . A rabbit polyclonal antibody specific for this phosphopeptide revealed IR-induced RAP80 phosphorylation (Fig. 1C) . S101 represents a potential ATM (ataxia telangiectasia mutated) protein kinase phosphorylation site, given its contribution to a serine-glutamine (SQ) motif (12) . Indeed, it was not phosphorylated in response to 10 gray (Gy) IR in ATM lymphoblasts (Fig. 1D) . However, RAP80 IR-induced phosphorylation and DSB localization were independent of RAP80 interaction with BRCA1, as demonstrated in the BRCA1 BRCT-mutated HCC 1937 cell line (Fig. 1, E and F) .
A series of green fluorescent protein (GFP)-RAP80 deletion mutants were monitored for IRinduced colocalization with MDC1 ( fig. S2A) . A six-amino-acid deletion mutant was generated that removed the stretch of conserved glutamates spanning residues 103 to 108 (Δ103-108), creating a hypomorphic UIM2 (103 to 125) domain. This mutant was expressed at equivalent levels to wild-type (WT) RAP80 in stable cell lines, and it coimmunoprecipitated with BRCA1 like WT RAP80 ( fig. S2A ). However, RAP80Δ103-108 demonstrated greatly reduced colocalization with MDC1 at IRIF formation 1 hour after 6 Gy (85% for WT and 2% for RAP80Δ103-108, n > 200) ( Fig. 2A) . Similar results were obtained for RAP80 UIM1 deletion mutants ( fig. S2 ). These results suggest that RAP80 gains access to DSBs by cooperative UIM binding to ubiquitin or polyubiquitin. In this regard, a glutathione S-transferase (GST)-RAP80 fusion protein that included both UIM domains (residues 1 to 233) bound Lys 63 (K63) isopeptide-conjugated tetra-ubiquitin with higher efficiency than K48-linked ubiquitin tetramers (Fig. 2B) . A preference for polymers containing at least four ubiquitin molecules was observed for GST-RAP80 incubated with K63-linked ubiquitin polymers, each containing two to seven ubiquitin molecules (Fig. 2C) .
Ubiquitin can form polymers in vivo through any of its seven lysine residues (13) . K6 isopeptides are the preferred linkage catalyzed by in vitro BRCA1 E3 activity (14) (15) (16) . To test whether RAP80 can also interact with K6 linkages, we transfected human embryonic kidney 293T cells with expression vectors for ubiquitin species in which all lysine residues except one were mutated to arginine. This creates the in vivo synthesis of ubiquitin polymers containing defined isopeptide linkages. These chains, however, may also include endogenous ubiquitin and consequently may not be homogenous for a single, defined isopeptide linkage. In 293T cell lysates, GST-RAP80 bound to K6-and K63-linked polyubiquitin to a similar extent as to WT polyubiquitin, but did not recognize K48-linked polyubiquitin (Fig. 2D) . These data indicate a preference for K63-, and possibly K6-, but not K48-linked ubiquitin polymers. Moreover, a positive correlation exists between ubiquitin binding and DSB localization, because WT RAP80 bound equally well to K63-linked ubiquitin before and after damage, whereas the UIM2 deletion mutant Δ103-108 demonstrated reduced binding to polyubiquitin (Fig. 2E ). The RAP80 ubiquitin binding specificity observed in Fig. 2 , B to E, appears to be relevant to the types of ubiquitin structures present at DNA damage sites. HeLa cells were Supporting Online Material www.sciencemag.org/cgi/content/full/316/5828/1198/DC1 Materials and Methods Figs. S1 to S4 References and Notes transfected with vectors that produce different hemagglutinin (HA)-tagged ubiquitin chains, and colocalization of each ubiquitin species with BRCA1 at DNA damage sites was examined. BRCA1 colocalized with WT ubiquitin in about 75% of the cells examined and with either K6-or K63-linked ubiquitin in roughly 25% of the cells containing BRCA1 IRIF formation (Fig. 2F ). K48-linked ubiquitin did not form foci at DNA damage sites (n = 500 transfected cells).
These results suggest that RAP80 is a candidate BRCT-interacting protein required to target BRCA1 to DNA damage sites. After small interfering RNA (siRNA) RAP80 knockdown in HeLa cells, strong BRCA1 foci were observed in just 8% of cells, compared to 82% in control (Ct) cells (n > 200). This indicates that RAP80 is largely required for BRCA1 IRIF formation (Fig. 3A) . Moreover, WT RAP80 supported an interaction between the BRCT domain and ubiquitin, whereas the Δ103-108 mutant did not (Fig. 3B) , providing in vitro evidence that RAP80 can target BRCA1 to ubiquitinated structures.
BRCA1 IRIF formation depends on the presence of γH2AX and MDC1 (4, 7) . RAP80 also demonstrated a strong dependency on MDC1 expression for post-IR foci formation, with >80% of control cells showing eRAP80 foci and only 2% of MDC1-depleted cells exhibiting eRAP80 IRIF (Fig. 3C ). Ubiquitin DSB localization was also reduced in cells depleted for MDC1 (n > 200) (Fig. 3D) . As opposed to focus formation, BRCA1 homed to laser-induced DNA DSBs (stripes) at similar frequencies regardless of RAP80 or MDC1 expression (Fig. 3, E and F) . However, knockdown of RAP80 or MDC1 (17) each reduced the intensity of BRCA1 immunostaining at stripes (Fig. 3, E and F) , and RAP80 recruitment to laser stripes was also reduced in cells depleted of MDC1 (Fig. 3E) . These results point to an MDC1-dependent pathway that is necessary to recruit RAP80-BRCA1 complexes to polyubiquitin structures at DSBs.
To gain insight into the functional interaction between BRCA1 and RAP80, we purified epitope-tagged RAP80 complex(es). Mass spectrometry revealed the presence of BRCA1 and the BRCA1-BARD1-interacting proteins BRCC45 and BRCC36 (18) (Fig. 4A) . The abundance of a complex consisting of BRCA1-BARD1, RAP80, and BRCC36 increased in M phase-enriched cells during a nocodazole block compared with S phase-enriched cells that were collected after thymidine treatment (Fig. 4B ). This suggests that RAP80 exists in a BRCA1-BARD1-associated complex containing BRCC36 that is different from the BRCA1-BARD1-BACH1 complex that occurs primarily in S phase. Consistent with this model, RAP80 was required for eBRCC36 subcellular localization. Specifically, RAP80 knockdown disrupted BRCC36 IRIF (Fig. 4C ) and rendered BRCC36 more readily extractable from nuclear matrix and/or chromatin-rich fractions (Fig. 4D) . Conversely, BACH1 IRIF appeared independent of RAP80, and BACH1 knockdown did not affect either RAP80 or BRCA1 stripe localization ( fig. S4) (9) . Moreover, RAP80 and BRCC36 demonstrated similar contributions to BRCA1-dependent DNA damage responses, implying that they contribute to similar DNA damage response functions. In this regard, stable knockdown of RAP80 using either of two different RAP80 short hairpin RNAs (shRNAs) produced dose-dependent IR supersensitivity (Fig. 4E) , as previously reported for BRCC36 knockdown (19) . In addition, depletion of RAP80 by two different siRNAs, like BRCC36 knockdown, resulted in a partial disruption of the G2 phase cell cycle checkpoint after 2 Gy IR compared with controls (Fig. 4F ).
BRCA1 ubiquitin ligase activity is activated by DNA damage and is required for its G2 checkpoint function (16, 20) . BRCC36 bears homology to the JAMM domain family of deubiquitinating enzymes (DUBs) (21) , suggesting that, in addition to E3 activity, DUB activity may be involved in the checkpoint and repair functions of this specific BRCA1-BARD1 complex. Wild type and a double active site mutant, His 122 →Gln 122 (H122Q) and H124Q BRCC36, were purified from HeLa S3 cells and examined for DUB activity on K63-linked tetraubiquitin (K63-Ub 4 ). DUB activity was detected for WT BRCC36 but not for the mutant (Fig. 4G) , establishing that BRCC36 has DUB activity toward K63-linked ubiquitin substrates, the same structures to which RAP80 binds.
These data support a model wherein MDC1-dependent, non-K48-linked ubiquitin chains at DNA damage sites are used as a targeting mechanism by specific BRCA1 complexes (Fig.  4H) . Should this be a general phenomenon, RAP80 may represent the first in a new class of DNA repair proteins that uses tandem UIM domains as part of its recruitment to DSBs. In contrast to IRIF formation, incomplete BRCA1 localization at laser-induced DSBs still occurs in the absence of γH2AX (22), MDC1 (17), or RAP80 (Fig. 3, E and F) . These findings may reflect the fact that BRCA1/BARD1 heterodimers are components of multiple distinct complexes (9) and that each may access DSBs by different mechanisms. Taken together, these findings strongly suggest an essential role for ubiquitin recognition by a specific BRCA1 complex in the response to DSB formation. In addition, the synthesis and turnover of certain polyubiquitinated structures by BRCA1 E3 and BRCC36 DUB activities, respectively, may contribute to BRCA1-dependent DSB repair. Myc antibody immunoprecipitated material was separated by SDS-polyacrylamide gel electrophoresis, and immunoblotting (IB) was performed. (C) HeLa S3 cells stably expressing epitope tagged-WT or S101A mutant RAP80 were IR-treated, and lysates were probed with an antibody specific to phosphorylated (P) RAP80-S-101. E, Glu; L, Leu; N, Asn; R, Arg; and V, Val. (D) ATM −/− and +/+ and (E) HCC1937 cells were gamma irradiated, and IB was performed on cell lysates as indicated. (F) HCC1937 cells reconstituted with vector or WT BRCA1 were transfected with GFP-RAP80 and gamma-irradiated, and, 1 hour later, IF was performed to assess colocalization with γH2AX. 
